Latest / Bloomberg Intelligence
Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion
Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney, Alexis Christoforous, and Stacey Vanek Smith
-Madison Muller, Bloomberg News Health Reporter, discusses news that Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion to establish itself as a leader in other areas and become a major player in infectious diseases.
-Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses Quantinuum seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.